This is a randomized, double-blind, placebo-controlled, parallel group study. The use of placebo is appropriate to minimize bias related to treatment expectations of the subject, study partner, and site investigator, as well as to changes in the relationship between the subject and study partner that might occur with the initiation of treatment and expectation of improvement in motor symptoms or cognition. Changes in subject/study partner interactions can impact subject mood and might introduce biases that cannot be quantified. The double-blind use of placebo will also prevent bias in the clinical and scientific assessments.
Male or female outpatients.
At least 50 years of age, but less than 90 (89 at time of screening)
Females must be surgically sterile (bilateral tubal ligation, oophorectomy, or hysterectomy) or postmenopausal for 2 years (no women at risk of pregnancy will be accepted in this study).
Must have been diagnosed with amnestic MCI based on the most recent NIA-AA criteria (Albert et al., 2011), i.e. at both the screening and baseline visits (visits 1 and 2) have a documented Mini Mental State Exam (MMSE) score between 22-28.
Current evidence or history within the last 3 years of a neurological or psychiatric illness that could contribute to dementia, including (but not limited to) epilepsy, focal brain lesion, Parkinson's disease, seizure disorder, head injury with loss of consciousness
DSM IV criteria for any major psychiatric disorder including psychosis, major depression and bipolar disorder.
Unwilling or unable to undergo a Lumbar Puncture.
Known history or self-reported alcohol or substance abuse.
Parallel
Lenalidomide 10 mg
DrugLenalidomide is a cancer drug, It is also known by it's brand name Revlimid.
To assess the effect of lenalidomide
To assess the effect of lenalidomide on inflammatory markers in CSF and blood, as well as safety and toxicity.
To asses the effect of lenalidomide
: To assess the effects of lenalidomide on CSF makers of AD (e.g. amyloid beta and tau levels) in aMCI patients
Click on the lead sponsor to view all of their trials.
St. Joseph's Hospital and Medical Center, Phoenix
Lead sponsor
Texas Tech University
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
